Adrienne Farid is COO at Century Therapeutics, Inc. (IPSC). They have made 9 open-market trades across 1 company since 2024, most recently 2025-06-09.
CIK 0001867310
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IPSC | 250,141 | $345K |
Shares reported on the most recent Form 4, priced at the 2025-06-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IPSC | SELL | 2025-06-09 | 2025-06-11 | $0.62 | $342 | -4.9% | -3.9% | -19.5% |
| IPSC | SELL | 2025-05-05 | 2025-05-07 | $0.55 | $563 | +10.9% | +23.3% | +11.6% |
| IPSC | SELL | 2025-03-10 | 2025-03-12 | $0.62 | $1K | -1.1% | -18.6% | +7.6% |
| IPSC | SELL | 2025-02-03 | 2025-02-05 | $0.78 | $822 | -3.0% | -17.2% | -33.1% |
| IPSC | SELL | 2024-11-04 | 2024-11-05 | $1.23 | $1K | -15.9% | -1.4% | -46.2% |
| IPSC | SELL | 2024-08-05 | 2024-08-07 | $1.83 | $2K | -5.0% | -18.9% | -26.1% |
| IPSC | SELL | 2024-05-03 | 2024-05-07 | $3.11 | $3K | -10.4% | -10.1% | -44.6% |
| IPSC | SELL | 2024-03-06 | 2024-03-08 | $5.04 | $539K | -4.9% | -28.3% | -42.7% |
| IPSC | SELL · 10b5-1 | 2024-02-16 | 2024-02-21 | $4.86 | $2K | -0.2% | +7.8% | -27.7% |
| IPSC | SELL | 2024-02-05 | 2024-02-07 | $4.14 | $16K | +2.7% | +16.7% | -24.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.